Report Content
Chapter 1 Methodology & Scope
1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 COVID-19 impact analysis at global level
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Transradial access devices industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Transradial Access Devices Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cardiovascular disease in developed and developing economies
3.2.1.2 Growing geriatric population base globally
3.2.1.3 Rising preference for interventional procedures using radial artery access
3.2.1.4 Growing use of radial access devices in pediatric patients
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory framework
3.2.2.2 High cost and maintenance of vascular access devices
3.2.2.3 Dearth of cardiothoracic surgeons in developing nations
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end-use
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Technology landscape
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Medtronic
4.1.2 Becton Dickinson and Company
4.1.3 Boston Scientific Corporation
4.1.4 Terumo Corporation
4.2 Competitive analysis of major market players
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Transradial Access Devices Market, By Product
5.1 Key product trends
5.2 Catheters
5.2.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Guidewires
5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Sheath and sheath introducers
5.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Accessories
5.5.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 6 Transradial Access Devices Market, By Application
6.1 Key application trends
6.2 Drug administration
6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Fluid and nutrition administration
6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Blood transfusion
6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Diagnostics and testing
6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Others
6.6.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 7 Transradial Access Devices Market, By End-use
7.1 Key end-use trends
7.2 Hospitals and clinics
7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers
7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Others
7.4.1 Market size, by region, 2018 - 2032 (USD Million)
Chapter 8 Transradial Access Devices Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018 - 2032 (USD Million)
8.2.2 Market size, by product, 2018 - 2032 (USD Million)
8.2.3 Market size, by application, 2018 - 2032 (USD Million)
8.2.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.2.5.2 Market size, by application, 2018 - 2032 (USD Million)
8.2.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.2.6.2 Market size, by application, 2018 - 2032 (USD Million)
8.2.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018 - 2032 (USD Million)
8.3.2 Market size, by product, 2018 - 2032 (USD Million)
8.3.3 Market size, by application, 2018 - 2032 (USD Million)
8.3.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.5.2 Market size, by application, 2018 - 2032 (USD Million)
8.3.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.6.2 Market size, by application, 2018 - 2032 (USD Million)
8.3.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.7.2 Market size, by application, 2018 - 2032 (USD Million)
8.3.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.8 Spain
8.3.8.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.8.2 Market size, by application, 2018 - 2032 (USD Million)
8.3.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.3.9 Italy
8.3.9.1 Market size, by product, 2018 - 2032 (USD Million)
8.3.9.2 Market size, by application, 2018 - 2032 (USD Million)
8.3.9.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018 - 2032 (USD Million)
8.4.2 Market size, by product, 2018 - 2032 (USD Million)
8.4.3 Market size, by application, 2018 - 2032 (USD Million)
8.4.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.5 China
8.4.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.5.2 Market size, by application, 2018 - 2032 (USD Million)
8.4.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.6 Japan
8.4.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.6.2 Market size, by application, 2018 - 2032 (USD Million)
8.4.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.7.2 Market size, by application, 2018 - 2032 (USD Million)
8.4.7.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by product, 2018 - 2032 (USD Million)
8.4.8.2 Market size, by application, 2018 - 2032 (USD Million)
8.4.8.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018 - 2032 (USD Million)
8.5.2 Market size, by product, 2018 - 2032 (USD Million)
8.5.3 Market size, by application, 2018 - 2032 (USD Million)
8.5.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.5 Brazil
8.5.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.5.5.2 Market size, by application, 2018 - 2032 (USD Million)
8.5.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.5.6 Mexico
8.5.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.5.6.2 Market size, by application, 2018 - 2032 (USD Million)
8.5.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6 Middle East and Africa
8.6.1 Market size, by country, 2018 - 2032 (USD Million)
8.6.2 Market size, by product, 2018 - 2032 (USD Million)
8.6.3 Market size, by application, 2018 - 2032 (USD Million)
8.6.4 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.5 South Africa
8.6.5.1 Market size, by product, 2018 - 2032 (USD Million)
8.6.5.2 Market size, by application, 2018 - 2032 (USD Million)
8.6.5.3 Market size, by end-use, 2018 - 2032 (USD Million)
8.6.6 Saudi Arabia
8.6.6.1 Market size, by product, 2018 - 2032 (USD Million)
8.6.6.2 Market size, by application, 2018 - 2032 (USD Million)
8.6.6.3 Market size, by end-use, 2018 - 2032 (USD Million)
Chapter 9 Company Profiles
9.1 Ameco Medical Industries
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Product landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 AngioDynamics
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Becton Dickinson and Company
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Boston Scientific Corporation
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Edward Lifesciences Corporation
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Medtronic
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Merit Medical System, Inc.
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 NIPRO Medical Corporation
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Oscor Inc
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Smiths Group
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Teleflex Corporation
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 Terumo Corporation
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
